Wells Fargo’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.69M | Sell |
123,359
-93,119
| -43% | -$1.28M | ﹤0.01% | 3020 |
|
|
2025
Q1 | $2.39M | Sell |
216,478
-5,062
| -2% | -$56K | ﹤0.01% | 2691 |
|
|
2024
Q4 | $2.36M | Buy |
221,540
+5,801
| +3% | +$61.8K | ﹤0.01% | 2706 |
|
|
2024
Q3 | $2.74M | Sell |
215,739
-102
| -0% | -$1.3K | ﹤0.01% | 2542 |
|
|
2024
Q2 | $3.62M | Buy |
215,841
+3,561
| +2% | +$59.8K | ﹤0.01% | 2283 |
|
|
2024
Q1 | $3.18M | Sell |
212,280
-6,801
| -3% | -$102K | ﹤0.01% | 2352 |
|
|
2023
Q4 | $3.29M | Buy |
219,081
+2,548
| +1% | +$38.2K | ﹤0.01% | 2275 |
|
|
2023
Q3 | $3.03M | Sell |
216,533
-211,004
| -49% | -$2.96M | ﹤0.01% | 2299 |
|
|
2023
Q2 | $4.42M | Buy |
427,537
+3,997
| +0.9% | +$41.4K | ﹤0.01% | 2131 |
|
|
2023
Q1 | $3.91M | Buy |
423,540
+34,365
| +9% | +$318K | ﹤0.01% | 2187 |
|
|
2022
Q4 | $3.45M | Sell |
389,175
-3,963
| -1% | -$35.2K | ﹤0.01% | 2219 |
|
|
2022
Q3 | $3.27M | Buy |
393,138
+2,475
| +0.6% | +$20.6K | ﹤0.01% | 2197 |
|
|
2022
Q2 | $3.2M | Buy |
390,663
+136,671
| +54% | +$1.12M | ﹤0.01% | 2308 |
|
|
2022
Q1 | $2.21M | Buy |
253,992
+83,099
| +49% | +$724K | ﹤0.01% | 3022 |
|
|
2021
Q4 | $1.63M | Buy |
170,893
+36,456
| +27% | +$347K | ﹤0.01% | 3464 |
|
|
2021
Q3 | $2.26M | Buy |
134,437
+114,521
| +575% | +$1.93M | ﹤0.01% | 3385 |
|
|
2021
Q2 | $304K | Buy |
19,916
+15,663
| +368% | +$239K | ﹤0.01% | 4576 |
|
|
2021
Q1 | $83K | Sell |
4,253
-29,768
| -87% | -$581K | ﹤0.01% | 5224 |
|
|
2020
Q4 | $613K | Buy |
34,021
+5,653
| +20% | +$102K | ﹤0.01% | 4306 |
|
|
2020
Q3 | $547K | Sell |
28,368
-4,512
| -14% | -$87K | ﹤0.01% | 4165 |
|
|
2020
Q2 | $859K | Buy |
32,880
+20,666
| +169% | +$540K | ﹤0.01% | 3826 |
|
|
2020
Q1 | $218K | Buy |
12,214
+1,699
| +16% | +$30.3K | ﹤0.01% | 4465 |
|
|
2019
Q4 | $351K | Buy |
10,515
+710
| +7% | +$23.7K | ﹤0.01% | 4514 |
|
|
2019
Q3 | $233K | Buy |
9,805
+1,464
| +18% | +$34.8K | ﹤0.01% | 4696 |
|
|
2019
Q2 | $300K | Buy |
+8,341
| New | +$300K | ﹤0.01% | 4579 |
|
|
2019
Q1 | – | Sell |
-15,181
| Closed | -$653K | – | 6097 |
|
|
2018
Q4 | $653K | Sell |
15,181
-3,008
| -17% | -$129K | ﹤0.01% | 4061 |
|
|
2018
Q3 | $859K | Sell |
18,189
-682
| -4% | -$32.2K | ﹤0.01% | 3996 |
|
|
2018
Q2 | $939K | Buy |
18,871
+17,881
| +1,806% | +$890K | ﹤0.01% | 3972 |
|
|
2018
Q1 | $49K | Buy |
+990
| New | +$49K | ﹤0.01% | 5279 |
|